Home
A clearer picture, a brighter tomorrow. APRINOIA offers patients with neurodegenerative diseases the hope of protecting their brain wealth and preserving their dignity through next-generation diagnostic tools and targeted therapeutics. Our Approach At APRINOIA, we bring precision medicine to neuroscience by identifying and targeting the protein aggregates of tau, α-synuclein, and other proteins that play […]
Hsiou-Chi Liou, Ph.D, CFA
Hsiou-Chi Liou, Ph.D., CFA Head, Corporate Development and Strategy APRINOIA Director of Finance, APRINOIA Therapeutics Portfolio Advisor, Bank of America Merrill Lynch Equity Analyst, Biovantage Investments Co-founder, ImmuneTarget Faculty, Weill Cornell Medical College Postdoctoral fellow, MIT and Rockefeller University PhD, Harvard School of Public Health MS in Cytogenetics, National Taiwan University Drug discovery in immunological […]
APRINOIA Therapeutics Announces Mutual Termination of Business Combination Agreement with ROSS Acquisition Corp II
APRINOIA Therapeutics Announces Mutual Termination of Business Combination Agreement with ROSS Acquisition Corp II CAMBRIDGE, Mass., Aug. 23, 2023 (GLOBE NEWSWIRE) — APRINOIA Therapeutics (“APRINOIA”), a global clinical-stage biopharmaceutical company developing novel therapeutics and precision diagnostics for the treatment of neurodegenerative diseases such as Alzheimer’s Disease (“AD”) and Progressive Supranuclear Palsy (“PSP”), announced a mutual […]
Sr. Scientist
Senior Scientist APRINOIA Therapeutics, LLC is seeking a creative and highly motivated scientist to apply innovative medicinal chemistry principles and techniques toward the discovery of medicines for neuroscience as a key contributor to APRINOIA’s business and support the successful discovery and development of the next generation of diagnostic and therapeutic products for the treatment of […]
Lili Zhang, Ph.D
Lili Zhang, Ph.D. Senior Vice President, Head of Preclinical Development APRINOIA Senior Director, Dewpoint Therapeutics, Boston, MA Senior Director, Aquinnah Pharmaceutics, Cambridge, MA Senior Investigator, Novartis Institute of Biomedical Research (NIBR), Cambridge, MA Director, Merck Research Laboratories (MRL), Kenilworth, NJ Postdoc in Molecular Cancer Biology, Duke University Medical Center Ph.D in Plant Biology, University of […]
Chin-Yin Tai, Ph.D
Chin-Yin Tai, Ph.D. Vice President of Neurobiology APRINOIA Acting Director, the Development Center for Biotechnology, Taiwan Assistant research fellow, Academia Sinica, Taiwan Postdoc in Neurobiology, Caltech Ph.D in Cell Biology, University of Massachusetts, Medical School Molecular mechanism of neuronal adhesion molecule in synaptic plasticity, AD and ALS drug discovery View all team members →
Masaomi Miyamoto, Ph.D
Masaomi Miyamoto, Ph.D Executive Vice President of R&D and Operations APRINOIA Japan Managing Director, Seikagaku, Japan General Manager, Director for Drug Discovery, Takeda, Japan Ph.D, Kyushu University, Japan MS in Pharmaceutical Sciences, Kyushu University, Japan CNS pharmacology, Alzheimer’s disease and sleep disorder, drug development: TRH-T (Hiltonin™), idebenone (Avan™), ramelteon (Rozerem™) View all team members →
Ming-Kuei Jang, Ph.D
Ming-Kuei Jang, Ph.D. Founder, Chairman, and Chief Executive Officer APRINOIA CEO, Aprinoia Therapeutics Neurodegeneration Consortium, MD Anderson Cancer Center, Houston Associate Director, GlaxoSmithKline, Shanghai Senior Research Biologist, Merck & CO, Boston Postdoc in Neurophysiology at Northwestern University and Columbia University Ph.D in Pharmacology and Neuroscience, Boston University BS in Chemistry, National Taiwan University, Taiwan Neurodegenerative […]
Accessibility Statement
Accessibility Statement Last updated: May 04, 2022 Our Commitment to Accessibility We (APRINOIA Therapeutics Inc.) are committed to employing assistive technologies to make our website accessible to everyone. We have built this website in a manner to work with assistive technologies using the Worldwide Web Consortium’s Web Content Accessibility Guidelines (WCAG) and will continue to […]
Cookie Policy
Cookies Policy Last updated: May 04, 2022 This Cookies Policy explains what Cookies are and how We use them. You should read this policy so You can understand what type of cookies We use, or the information We collect using Cookies and how that information is used. Cookies do not typically contain any information that […]